Dr Delphine Rea is appointed at Saint-Louis University Hospital, Paris, France, where she works as a physician in the Department of Hematology.
Her main clinical and research interest focuses on malignant myeloid disorders. She is responsible for the Chronic Myeloid Leukemia clinical care and research program. She has been the principal investigator or investigator of many academic- or industry-sponsored clinical trials dedicated to CML, including pivotal studies that have led to the approval of tyrosine kinase inhibitors or treatment-free remission studies.

She belongs to the board of directors of the French cooperative group of CML (Fi-LMC), contributes to the CML project of the European LeukemiaNet, to the organization committee of European School of Haematology (ESH) iCMLf annual conference, to the Society of Hematologic Oncology (SOHO) annual meeting education committee and to the scientific advisory board of iCMLf.